Vital Therapies reported $86.65M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Insmed INSM:US USD 632.16M 42.56M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Omeros OMER:US USD 288.54M 95.82M
Orasure Technologies OSUR:US USD 279.73M 12.43M
Quidel QDEL:US USD 1.45B 113.9M
Regulus Therapeutics RGLS:US USD 49.37M 2.02M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
United Therapeutics UTHR:US USD 3.06B 372.1M
Vital Therapies VTL:US USD 86.65M 18.11M
Xoma XOMA:US USD 79.74M 7.52M